Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Duisburg-Essen, Wickenburgstr. 21, 45147 Essen, Germany.
J Psychiatr Res. 2012 Dec;46(12):1600-9. doi: 10.1016/j.jpsychires.2012.08.015. Epub 2012 Sep 12.
Starvation represents an extreme physiological state and entails numerous endocrine and metabolic adaptations. The large-scale application of metabolomics to patients with acute anorexia nervosa (AN) should lead to the identification of state markers characteristic of starvation in general and of the starvation specifically associated with this eating disorder. Novel metabolomics technology has not yet been applied to this disorder. Using a targeted metabolomics approach, we analysed 163 metabolite concentrations in 29 patients with AN in the acute stage of starvation (T0) and after short-term weight recovery (T1). Of the 163 metabolites of the respective kit, 112 metabolites were quantified within restrictive quality control limits. We hypothesized that concentrations are different in patients in the acute stage of starvation (T0) and after weight gain (T1). Furthermore, we compared all 112 metabolite concentrations of patients at the two time points (T0, T1) with those of 16 age and gender matched healthy controls. Thirty-three of the metabolite serum levels were found significantly different between T0 and T1. At the acute stage of starvation (T0) serum concentrations of 90 metabolites differed significantly from those of healthy controls. Concentrations of controls mostly differed even more strongly from those of AN patients after short-term weight recovery than at the acute stage of starvation. We conclude that AN entails profound and longer lasting alterations of a large number of serum metabolites. Further studies are warranted to distinguish between state and trait related alterations and to establish diagnostic sensitivity and specificity of the thus altered metabolites.
饥饿代表一种极端的生理状态,需要进行许多内分泌和代谢适应。将代谢组学大规模应用于急性神经性厌食症(AN)患者,应该可以识别出一般饥饿状态以及与这种饮食障碍相关的特定饥饿的特征性状态标志物。目前尚未将新型代谢组学技术应用于这种疾病。本研究采用靶向代谢组学方法,分析了 29 名处于急性饥饿期(T0)和短期体重恢复后(T1)的 AN 患者的 163 种代谢物浓度。在相应试剂盒的 163 种代谢物中,有 112 种代谢物的浓度在严格的质量控制范围内。我们假设,处于急性饥饿期(T0)的患者和体重增加后的患者(T1)之间的浓度存在差异。此外,我们将两个时间点(T0、T1)的所有 112 种代谢物浓度与 16 名年龄和性别匹配的健康对照组进行了比较。在 T0 和 T1 之间,有 33 种代谢物血清水平存在显著差异。在急性饥饿期(T0),90 种代谢物的血清浓度与健康对照组有显著差异。与急性饥饿期相比,体重恢复后的健康对照组的浓度与 AN 患者的浓度差异更大。我们得出结论,AN 会导致大量血清代谢物发生深刻而持久的改变。需要进一步研究以区分状态和特征相关的改变,并建立由此改变的代谢物的诊断敏感性和特异性。